Company: DVAX
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001029142-25-000049
Chunk: 53

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-20
Form: 10-K
Item: Item 15
Chunk 53
---
27, 2023, by and between Company and Coalition for Epidemic Preparedness Innovations10.210-QAugust 3, 2023001-3420710.34^Supply Agreement, dated effective April 1, 2021, between Company and Becton, Dickinson and Company10.3510-KFebruary 23, 2023001-3420710.35^Amendment #1 to Supply Agreement, dated September 28, 2022, between Company and Becton, Dickinson and Company10.3610-KFebruary 23, 2023001-3420710.36^Supply Agreement, dated June 29, 2021, by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., and Clover Biopharmaceuticals (Hong Kong) Co., Limited10.610-QAugust 4, 2021001-3420710.37^Letter Agreement, dated August 30, 2022, by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., Clover Biopharmaceuticals (Hong Kong) Co., Limited and Sichuan Clover Biopharmaceuticals, Inc.10.210-QNovember 3, 2022001-3420710.38^Letter Agreement No. 2, dated October 31, 2022, by and among Company, Zhejiang Clover Biopharmaceuticals, Inc. and Clover Biopharmaceuticals (Hong Kong) Co., Limited10.410-QNovember 3, 2022001-3420710.39^Amendment No. 3 to Supply Agreement, effective August 15, 2022, by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., and Clover Biopharmaceuticals (Hong Kong) Co., Limited10.3710-KFebruary 23, 2023001-3420710.40^Amendment No. 4 to Supply Agreement, effective September 23, 2022, by and among Company, Zhejiang Clover Biopharmaceuticals, Inc., and Clover Biopharmaceuticals (Hong Kong) Co., Limited10.3810-KFebruary 23, 2023001-3420710.41^Supply Agreement, dated July 1, 2021, by and between Company and Biological E. Limited10.710-QAugust 4, 2021001-3420710.42^Amendment